Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwin D Dhanda

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
World Journal of Gastroenterology|April 5, 2017
Infection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroidsAshwin D Dhanda, Ashish Sinha, Vicky Hunt, et al.
Gut and Liver|June 4, 2019
<i>Ex Vivo</i> T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic HepatitisAshwin D Dhanda, Euan Yates, Lauren P Schewitz-Bowers, et al.
Biomarker Research|December 22, 2016
Development and validation of a novel bioassay to determine glucocorticoid sensitivityEmily L Williams, Madeleine L Stimpson, Peter L Collins, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2024
Proactive case finding of alcohol-related liver disease in high-risk populations: A systematic reviewAnn J Archer, Jennifer Phillips, Mohsan Subhani, et al.
Immunobiology|February 8, 2022
Patients with moderate to severe COVID-19 have an impaired cytokine response with an exhausted and senescent immune phenotypeAshwin D Dhanda, Dan Felmlee, Paula Boeira, et al.
Hepatology (Baltimore, Md.)|May 10, 2014
Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivityAshwin D Dhanda, Alex J di Mambro, Vicky L Hunt, et al.
British Journal of Haematology|December 18, 2020
Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14<sup>++</sup> CD16<sup>+</sup> intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotypeEmily L Williams, Madeleine L Stimpson, Philippa J P Lait, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2019
Intermediate Monocytes in Acute Alcoholic Hepatitis Are Functionally Activated and Induce IL-17 Expression in CD4<sup>+</sup> T CellsAshwin D Dhanda, Emily L Williams, Euan Yates, et al.
The Lancet. Gastroenterology & Hepatology|June 28, 2024
Breaking down barriers between liver, addiction, and mental health services for people with alcohol-related liver diseaseAshwin D Dhanda, Victoria Allgar, Neeraj Bhala, et al.
Gastroenterology|May 3, 2012
Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitisBruce E Sands, William J Sandborn, Tom J Creed, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
World Journal of Gastroenterology|April 5, 2017
Infection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroidsAshwin D Dhanda, Ashish Sinha, Vicky Hunt, et al.
Gut and Liver|June 4, 2019
<i>Ex Vivo</i> T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic HepatitisAshwin D Dhanda, Euan Yates, Lauren P Schewitz-Bowers, et al.
Biomarker Research|December 22, 2016
Development and validation of a novel bioassay to determine glucocorticoid sensitivityEmily L Williams, Madeleine L Stimpson, Peter L Collins, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2024
Proactive case finding of alcohol-related liver disease in high-risk populations: A systematic reviewAnn J Archer, Jennifer Phillips, Mohsan Subhani, et al.
Immunobiology|February 8, 2022
Patients with moderate to severe COVID-19 have an impaired cytokine response with an exhausted and senescent immune phenotypeAshwin D Dhanda, Dan Felmlee, Paula Boeira, et al.
Hepatology (Baltimore, Md.)|May 10, 2014
Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivityAshwin D Dhanda, Alex J di Mambro, Vicky L Hunt, et al.
British Journal of Haematology|December 18, 2020
Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14<sup>++</sup> CD16<sup>+</sup> intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotypeEmily L Williams, Madeleine L Stimpson, Philippa J P Lait, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2019
Intermediate Monocytes in Acute Alcoholic Hepatitis Are Functionally Activated and Induce IL-17 Expression in CD4<sup>+</sup> T CellsAshwin D Dhanda, Emily L Williams, Euan Yates, et al.
The Lancet. Gastroenterology & Hepatology|June 28, 2024
Breaking down barriers between liver, addiction, and mental health services for people with alcohol-related liver diseaseAshwin D Dhanda, Victoria Allgar, Neeraj Bhala, et al.
Gastroenterology|May 3, 2012
Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitisBruce E Sands, William J Sandborn, Tom J Creed, et al.
Pageof 3